The top documents tagged [leuk lymphoma]

Dr. Joy Frestedt, PhD, CCTI, RAC, FRAPS is President and CEO of Frestedt Incorporated Frestedt Incorporated 9445 Minnetonka Blvd St. Louis Park, MN, 55426
Documents Dr. Joy Frestedt, PhD, CCTI, RAC, FRAPS is President and CEO of Frestedt Incorporated Frestedt Incorporated 9445 Minnetonka Blvd St. Louis Park, MN, 55426

215 views

Support for pesticides playing a role in onset of multiple myeloma September 10, 2014 Ola Landgren, M.D., Ph.D. Chief, Myeloma Service Memorial Sloan-Kettering
Documents Support for pesticides playing a role in onset of multiple myeloma September 10, 2014 Ola Landgren, M.D., Ph.D. Chief, Myeloma Service Memorial Sloan-Kettering

213 views

HCL Patient Seminar September 2014 Quality of Life Monica Else
Documents HCL Patient Seminar September 2014 Quality of Life Monica Else

215 views

Malignant Pleural Mesothelioma Post- Irradiation Treatment for Hodgkin’s Lymphoma Thea Price MD, R.V. Sooppan MD, Michael Walker MD Department of Thoracic
Documents Malignant Pleural Mesothelioma Post- Irradiation Treatment for Hodgkin’s Lymphoma Thea Price MD, R.V. Sooppan MD, Michael Walker MD Department of Thoracic

212 views

Novel Agents for Indolent Lymphoma and Mantle Cell Lymphoma Stephen Ansell, MD, PhD Mayo Clinic
Documents Novel Agents for Indolent Lymphoma and Mantle Cell Lymphoma Stephen Ansell, MD, PhD Mayo Clinic

221 views

Smoldering Multiple Myeloma
Documents Smoldering Multiple Myeloma

89 views

Steven M. Horwitz M.D. Associate Attending Memorial Sloan-Kettering Cancer Center
Documents Steven M. Horwitz M.D. Associate Attending Memorial Sloan-Kettering Cancer Center

34 views

Novel Agents for Indolent L ymphoma and Mantle Cell Lymphoma
Documents Novel Agents for Indolent L ymphoma and Mantle Cell Lymphoma

21 views

In partnership with The Impact of Thalidomide Maintenance Therapy Varies According to Biological Risk Grouping Annamaria Brioli Fiona M Ross 3, Martin
Documents In partnership with The Impact of Thalidomide Maintenance Therapy Varies According to Biological Risk Grouping Annamaria Brioli Fiona M Ross 3, Martin

213 views

Andre Goy, MD Cancer Center Director Lymphoma Division Head John Theurer Cancer Center @ HUMC, NJ Chief Science Officer Research / Innovation RCCA Professor
Documents Andre Goy, MD Cancer Center Director Lymphoma Division Head John Theurer Cancer Center @ HUMC, NJ Chief Science Officer Research / Innovation RCCA Professor

224 views

Good Samaritan Medical Center, West Palm Beach, FL Guest Speaker Michael Savona, MD Associate Professor of Medicine Director, Hematology Early Therapeutics
Documents Good Samaritan Medical Center, West Palm Beach, FL Guest Speaker Michael Savona, MD Associate Professor of Medicine Director, Hematology Early Therapeutics

213 views

Lucio Crinò, MD Silvestrini Hospital Perugia, Italy
Documents Lucio Crinò, MD Silvestrini Hospital Perugia, Italy

85 views